Biology:Xanthine dehydrogenase

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example
xanthine dehydrogenase
1fo4.jpg
Bos taurus
Identifiers
EC number1.17.1.4
CAS number9054-84-6
Databases
IntEnzIntEnz view
BRENDABRENDA entry
ExPASyNiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Gene OntologyAmiGO / QuickGO

Xanthine dehydrogenase, also known as XDH, is a protein that, in humans, is encoded by the XDH gene.[1][2]

Function

Xanthine dehydrogenase belongs to the group of molybdenum-containing hydroxylases involved in the oxidative metabolism of purines. The enzyme is a homodimer. Xanthine dehydrogenase can be converted to xanthine oxidase by reversible sulfhydryl oxidation or by irreversible proteolytic modification.[1]

Xanthine dehydrogenase catalyzes the following chemical reaction:

Xanthine dehydrogenase.svg
xanthine + NAD+ + H2O [math]\displaystyle{ \rightleftharpoons }[/math] urate + NADH + H+

The three substrates of this enzyme are xanthine, NAD+, and H2O, whereas its three products are urate, NADH, and H+.

This enzyme participates in purine metabolism.

Nomenclature

This enzyme belongs to the family of oxidoreductases, to be specific, those acting on CH or CH2 groups with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is xanthine:NAD+ oxidoreductase. Other names in common use include NAD+-xanthine dehydrogenase, xanthine-NAD+ oxidoreductase, xanthine/NAD+ oxidoreductase, and xanthine oxidoreductase.

Clinical significance

Defects in xanthine dehydrogenase cause xanthinuria, may contribute to adult respiratory stress syndrome, and may potentiate influenza infection through an oxygen metabolite-dependent mechanism.[1] It has been shown that patients with lung adenocarcinoma tumors which have high levels of XDH gene expression have lower survivals.[3][4] Addiction to XDH protein has been used to target NSCLC tumors and cell lines in a precision oncology manner.[4]

See also

References

  1. 1.0 1.1 1.2 "Entrez Gene: XDH xanthine dehydrogenase". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7498. 
  2. "Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): structural analysis of the protein and chromosomal location of the gene". Gene 133 (2): 279–84. November 1993. doi:10.1016/0378-1119(93)90652-J. PMID 8224915. 
  3. "Acquired xanthine dehydrogenase expression shortens survival in patients with resected adenocarcinoma of lung". Tumour Biology 33 (5): 1727–32. October 2012. doi:10.1007/s13277-012-0431-2. PMID 22678977. 
  4. 4.0 4.1 "Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses". Molecular Oncology 13 (8): 1725–1743. May 2019. doi:10.1002/1878-0261.12521. PMID 31116490. 

Further reading

External links

  • Overview of all the structural information available in the PDB for UniProt: P47989 (Xanthine dehydrogenase/oxidase) at the PDBe-KB.